Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 17, 2022

SELL
$117.13 - $176.59 $2,459 - $3,708
-21 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $2,655 - $4,936
21 New
21 $4,000
Q4 2021

Jan 25, 2022

SELL
$225.82 - $368.51 $677 - $1,105
-3 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$221.9 - $484.47 $665 - $1,453
3 New
3 $1,000
Q1 2021

Apr 20, 2021

SELL
$109.18 - $185.98 $327 - $557
-3 Closed
0 $0
Q3 2020

Nov 18, 2020

BUY
$54.34 - $94.85 $163 - $284
3 New
3 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cordant, Inc. Portfolio

Follow Cordant, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cordant, Inc. with notifications on news.